| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $179.0M | $190.2M | $193.4M |
| YoY Revenue Growth % | -5.9% | -1.6% | — |
| Gross Profit | $103.8M | $128.4M | — |
| Gross Margin % | 58.0% | 67.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$61.9M | -$70.1M | -$57.6M |
| Operating Margin % | -34.6% | -36.9% | -29.8% |
| Net Income (GAAP) | -$39.9M | -$42.6M | -$40.2M |
| EBITDA (Normalized) | -$57.6M | -$64.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$18.8M | -$15.6M | -$7.6M |
| Capital Expenditures (CapEx) | $5.4M | $6.9M | — |
| Free Cash Flow (FCF) | -$24.2M | -$22.5M | -$7.6M |
| FCF Margin % | -13.5% | -11.8% | -3.9% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $47.9M | $52.5M | — |
| Total Debt (Short + Long Term) | $19.3M | $0 | — |
| Total Stockholders' Equity | $19.0M | $39.5M | — |